Abstract: The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them: wherein meanings of the substituents are indicated in the description. Such compounds for use in the treatment of cancer and other diseases related to altered angiogenesis, such as arthritic pathology, diabetic retinopathy, psoriasis and chronic inflammatory disease, are also within the scope of the present invention.
Type:
Grant
Filed:
December 6, 2021
Date of Patent:
November 21, 2023
Assignee:
BIOGEM S.C. A R.L.
Inventors:
Claudio Pisano, Sabrina Dallavalle, Raffaella Cincinelli, Lucio Merlini
Abstract: The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them: wherein meanings of the substituents are indicated in the description. Such compounds for use in the treatment of cancer and other diseases related to altered angiogenesis, such as arthritic pathology, diabetic retinopathy, psoriasis and chronic inflammatory disease, are also within the scope of the present invention.
Type:
Grant
Filed:
October 24, 2020
Date of Patent:
June 21, 2022
Assignee:
BIOGEM S.C. A R.L.
Inventors:
Claudio Pisano, Sabrina Dallavalle, Raffaella Cincinelli, Lucio Merlini
Abstract: The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them: wherein meanings of the substituents are indicated in the description. Such compounds for use in the treatment of cancer and other diseases related to altered angiogenesis, such as arthritic pathology, diabetic retinopathy, psoriasis and chronic inflammatory disease, are also within the scope of the present invention.
Type:
Grant
Filed:
September 28, 2017
Date of Patent:
February 2, 2021
Assignee:
BIOGEM S.C. A R.L.
Inventors:
Claudio Pisano, Sabrina Dallavalle, Raffaella Cincinelli, Lucio Merlini